FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3211996906> ?p ?o ?g. }

• W3211996906 endingPage "119" @default.
• W3211996906 startingPage "115" @default.
• W3211996906 abstract "Background In the last years immunotherapy has revolutionized the treatment of non-small cell lung cancer (NSCLC) not supported by a driver mutation. Immunotherapy related adverse events (irAEs) have a unique toxicity profiles distinct from the toxicities of classical chemotherapy treatment relating to their mechanism of action. We analyzed some serious and uncommon life-threatening irAEs, needing a change in the therapeutic strategy. Method Between October 2018 and October 2020, 63 NSCLC patients underwent immunotherapy. Thirty-eight patients underwent first-line Pembrolizumab, 200 mg every 21 days (Group A). Twenty patients were treated in second line with Pembrolizumab 200 mg every 21 days or Nivolumab 240 mg every 14 days or Atezolizumab 800 mg every 14 days (Group B). Five stage III patients treated after radio chemotherapy with Durvalumab 1500 mg every 14 days (Group C). Results We experienced: a) 2 bowel perforations (3.2%), necessitating Hartmann's resection. Only one of the two patients restored immunotherapy; b) 1 chronic renal insufficiency (1.6%, creatinine up to 8 mg/dL) and 2 severe hypertransaminasemias (3.2%, up to 65 U/L), requiring the immediate and definitive interruption of ICIs; c) 2 pericardial effusions (3.2%), of which one needed subxiphoid pericardiocentesis for cardiac tamponade. Patient restored immunotherapy after resolution of the acute event. Conclusions Immunotherapy include monoclonal antibodies reducing the suppression of effector T cells and improving the tumor-specific immune responses. Most common irAEs are evident in mild and reversible form, but sometimes life-threatening irEAs show up. Therefore, further clinical trials needed to increase knowledge of drugs and prevent unexpected irAEs." @default.
• W3211996906 created "2021-11-22" @default.
• W3211996906 creator A5011559696 @default.
• W3211996906 creator A5021379718 @default.
• W3211996906 creator A5027420799 @default.
• W3211996906 creator A5039992416 @default.
• W3211996906 creator A5046924418 @default.
• W3211996906 creator A5057661468 @default.
• W3211996906 creator A5075628688 @default.
• W3211996906 date "2021-07-10" @default.
• W3211996906 modified "2023-09-23" @default.
• W3211996906 title "NSCLC Immunotherapy and Related Rare Toxicities: A Monocentric Real-Life Experience." @default.
• W3211996906 cites W1964345250 @default.
• W3211996906 cites W1975578701 @default.
• W3211996906 cites W2076668534 @default.
• W3211996906 cites W2198093519 @default.
• W3211996906 cites W2265285917 @default.
• W3211996906 cites W2527905628 @default.
• W3211996906 cites W2567564314 @default.
• W3211996906 cites W2765836977 @default.
• W3211996906 cites W2889646458 @default.
• W3211996906 cites W2901191795 @default.
• W3211996906 cites W2947923244 @default.
• W3211996906 cites W2980537150 @default.
• W3211996906 cites W2995219807 @default.
• W3211996906 cites W3009099064 @default.
• W3211996906 cites W3120933346 @default.
• W3211996906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8570570" @default.
• W3211996906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34746934" @default.
• W3211996906 hasPublicationYear "2021" @default.
• W3211996906 type Work @default.
• W3211996906 sameAs 3211996906 @default.
• W3211996906 citedByCount "1" @default.
• W3211996906 countsByYear W32119969062022 @default.
• W3211996906 crossrefType "journal-article" @default.
• W3211996906 hasAuthorship W3211996906A5011559696 @default.
• W3211996906 hasAuthorship W3211996906A5021379718 @default.
• W3211996906 hasAuthorship W3211996906A5027420799 @default.
• W3211996906 hasAuthorship W3211996906A5039992416 @default.
• W3211996906 hasAuthorship W3211996906A5046924418 @default.
• W3211996906 hasAuthorship W3211996906A5057661468 @default.
• W3211996906 hasAuthorship W3211996906A5075628688 @default.
• W3211996906 hasConcept C121608353 @default.
• W3211996906 hasConcept C126322002 @default.
• W3211996906 hasConcept C141071460 @default.
• W3211996906 hasConcept C143998085 @default.
• W3211996906 hasConcept C197934379 @default.
• W3211996906 hasConcept C2775949291 @default.
• W3211996906 hasConcept C2776256026 @default.
• W3211996906 hasConcept C2777701055 @default.
• W3211996906 hasConcept C2777742743 @default.
• W3211996906 hasConcept C2778005868 @default.
• W3211996906 hasConcept C2778607678 @default.
• W3211996906 hasConcept C2780030458 @default.
• W3211996906 hasConcept C2780057760 @default.
• W3211996906 hasConcept C71924100 @default.
• W3211996906 hasConcept C90924648 @default.
• W3211996906 hasConceptScore W3211996906C121608353 @default.
• W3211996906 hasConceptScore W3211996906C126322002 @default.
• W3211996906 hasConceptScore W3211996906C141071460 @default.
• W3211996906 hasConceptScore W3211996906C143998085 @default.
• W3211996906 hasConceptScore W3211996906C197934379 @default.
• W3211996906 hasConceptScore W3211996906C2775949291 @default.
• W3211996906 hasConceptScore W3211996906C2776256026 @default.
• W3211996906 hasConceptScore W3211996906C2777701055 @default.
• W3211996906 hasConceptScore W3211996906C2777742743 @default.
• W3211996906 hasConceptScore W3211996906C2778005868 @default.
• W3211996906 hasConceptScore W3211996906C2778607678 @default.
• W3211996906 hasConceptScore W3211996906C2780030458 @default.
• W3211996906 hasConceptScore W3211996906C2780057760 @default.
• W3211996906 hasConceptScore W3211996906C71924100 @default.
• W3211996906 hasConceptScore W3211996906C90924648 @default.
• W3211996906 hasIssue "3" @default.
• W3211996906 hasLocation W32119969061 @default.
• W3211996906 hasOpenAccess W3211996906 @default.
• W3211996906 hasPrimaryLocation W32119969061 @default.
• W3211996906 hasRelatedWork W2060844658 @default.
• W3211996906 hasRelatedWork W2588317476 @default.
• W3211996906 hasRelatedWork W2613154644 @default.
• W3211996906 hasRelatedWork W2791605161 @default.
• W3211996906 hasRelatedWork W2796737583 @default.
• W3211996906 hasRelatedWork W2806287976 @default.
• W3211996906 hasRelatedWork W280698033 @default.
• W3211996906 hasRelatedWork W2939063244 @default.
• W3211996906 hasRelatedWork W2940608633 @default.
• W3211996906 hasRelatedWork W2951643410 @default.
• W3211996906 hasRelatedWork W2957956603 @default.
• W3211996906 hasRelatedWork W2985510368 @default.
• W3211996906 hasRelatedWork W2994651425 @default.
• W3211996906 hasRelatedWork W3033606695 @default.
• W3211996906 hasRelatedWork W3039495616 @default.
• W3211996906 hasRelatedWork W3111790665 @default.
• W3211996906 hasRelatedWork W3153135310 @default.
• W3211996906 hasRelatedWork W3173406294 @default.
• W3211996906 hasRelatedWork W3180220590 @default.
• W3211996906 hasRelatedWork W3206459045 @default.
• W3211996906 hasVolume "4" @default.
• W3211996906 isParatext "false" @default.

• next